Guillain-Barré syndrome: advances in pathogenic understanding and diagnostic improvements

Bibliography

• Yuki N, Hartung HP. Guillain–Barré syndrome. N Engl J Med 2012;366:2294-304
   PubMed Web of Science ®Google Scholar
• Guillain G, Barré JA, Strohl A. Sur un syndrome de radiculonévrite avec hyperalbuminose du liquide céphalo-rachidien sans réaction cellulaire: remarques sur les caractères cliniques et graphiques des réflexes tendineux. Bull Mem Hop Paris 1916;40:1462-70
   Google Scholar
• Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956;255:57-65
   PubMed Web of Science ®Google Scholar
• Bickerstaff ER. Brain-stem encephalitis: further observations on a grave syndrome with benign prognosis. Br Med 1957;1:1384-7
   PubMed Web of Science ®Google Scholar
• Ropper AH. Unusual clinical variants and signs in Guillain-Barré syndrome. Arch Neurol 1986;43:1150-2
   PubMed Web of Science ®Google Scholar
• Ropper AH. Further regional variants of acute immune polyneuropathy: bifacial weakness or sixth nerve paresis with paresthesias, lumbar polyradiculopathy, and ataxia with pharyngeal-cervical-brachial weakness. Arch Neurol 1994;51:671-5
   PubMedGoogle Scholar
• McKhann GM, Cornblath R, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute fl accid paralysis in China. Ann Neurol 1993;33:333-42
   PubMed Web of Science ®Google Scholar
• Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM, antibodies following Campylobacter enteritis. Neurology 1990;40:1900-2
   PubMed Web of Science ®Google Scholar
• Chiba A, Kusunoki S, Shirnizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 1992;31:677-9
   PubMed Web of Science ®Google Scholar
• Yuki N, Yamada M, Michiaki K, et al. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 2001;49:712-20
   PubMed Web of Science ®Google Scholar
• Susuki K, Yuki N, Schafer DP, et al. Dysfunction of nodes of Ranvier: a mechanism for antiganglioside antibody-mediated neuropathies. Exp Neurol 2012;233:534-42
   Google Scholar
• Yuki N, Sato S, Tsuji S, et al. An immunologic abnormality common to Bickerstaff’s brain stem encephalitis and Fisher’s syndrome. J Neurol Sci 1993;118:83-7
   PubMed Web of Science ®Google Scholar
• Sekiguchi Y, Uncini A, Yuki N, et al. Antiganglioside antibodies are associated with axonal Guillain–Barré syndrome: a Japanese-Italian collaborative study. J Neurol Neurosurg Psychiatry 2012;83:23-8
   PubMed Web of Science ®Google Scholar
• Kim JK, Bae JS, Kim DS, et al. Prevalence of anti-ganglioside antibodies and their clinical correlates with Guillain-Barré syndrome in Korea: a nationwide multicenter study. J Clin Neurol 2014;10:94-100
   PubMed Web of Science ®Google Scholar
• Prüss H, Schwab JM, Derst C, et al. Neurofascin as target of autoantibodies in Guillain-Barré syndrome. Brain 2011;134:1-2
   Google Scholar
• Devaux JJ, Odaka M, Yuki N. Nodal proteins are target antigens in Guillain-Barré syndrome. J Peripher Nerv Syst 2012;17:62-71
   PubMed Web of Science ®Google Scholar
• Lonigro A, Devaux JJ. Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis. Brain 2009;132:260-73
   PubMed Web of Science ®Google Scholar
• Zonta B, Tait S, Melrose S, et al. Glial and neuronal isoforms of neurofascin have distinct roles in the assembly of nodes of Ranvier in the central nervous system. J Cell Biol 2008;181:1169-77
   PubMedGoogle Scholar
• Sherman DL, Tait S, Melrose S, et al. Neurofascins are required to establish axonal domains for saltatory conduction. Neuron 2005;48:737-42
   PubMed Web of Science ®Google Scholar
• Ng JKM, Malotka J, Kawakami N, et al. Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology 2012;79:2241-8
   PubMed Web of Science ®Google Scholar
• Labasque M, Hivert B, Nogales-Gadea G, et al. Specific contactin N-glycans are implicated in neurofascin binding and autoimmune targeting in peripheral neuropathies. J Biol Chem 2014;289:7907-18
   Google Scholar
• Sawai S, Satoh M, Mori M, et al. Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barré syndrome. Neurology 2014;83:113-17
   Google Scholar
• Miyaji K, Devaux J, Yuki N. Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barré syndrome. Neurology 2014;83:2314
   Google Scholar
• Rosch RE, Bamford A, Hacohen Y, et al. Guillain-Barré syndrome associated with CASPR2 antibodies: two paediatric cases. J Peripher Nerv Syst 2014;19:246-9
   Google Scholar
• Tüzün E, Kinay D, Hacohen Y, et al. Guillain-Barré-like syndrome associated with lung adenocarcinoma and CASPR2 antibodies. Muscle Nerve 2013;48:836-7
   Google Scholar
• Willison HJ, Goodyear CS. Glycolipid antigens and autoantibodies in autoimmune neuropathies. Trends Immunol 2013;34:453-9
   PubMed Web of Science ®Google Scholar
• Rinaldi S, Brennan KM, Kalna G, et al. Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome. PLoS One 2013;8:e82337
   Google Scholar
• Shahrizaila N, Kokubun N, Sawai S, et al. Antibodies to single glycolipids and glycolipid complexes in Guillain-Barré syndrome subtypes. Neurology 2014;83:118-24
   Google Scholar
• Kuwahara M, Suzuki S, Takada K, Kusunoki S. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain–Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 2011;239:87-90
   Google Scholar
• Ogawa G, Kaida K, Kuwahara M, et al. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain–Barré syndrome with reversible conduction failure. J Neuroimmunol 2013;254:141-5
   Google Scholar
• Créange A, Shahrizaila N, Salhi H, et al. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy. J Peripher Nerv Syst 2014;19:115-20
   Google Scholar
• Susuki K, Rasband MN, Tohyama K, et al. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 2007;27:3956-67
   PubMed Web of Science ®Google Scholar
• Kokubun N, Nishibayashi M, Uncini A, et al. Conduction block in acute motor axonal neuropathy. Brain 2010;133:2897-908
   PubMed Web of Science ®Google Scholar
• Albers JW, Donofrio PD, Mcgonagle TK. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1985;8:528-39
   PubMed Web of Science ®Google Scholar
• Uncini A, Manzoli C, Notturno F, Capasso M. Pitfalls in electrodiagnosis of Guillain-Barré syndrome subtypes. J Neurol Neurosurg Psychiatry 2010;81:1157-63
   PubMed Web of Science ®Google Scholar
• Kokubun N, Shahrizaila N, Hirata K, Yuki N. Reversible conduction failure is distinct from neurophysiological patterns of recovery in mild demyelinating Guillain–Barré syndrome. J Neurol Sci 2013;326:111-14
   Google Scholar
• Uncini A, Susuki K, Yuki N. Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies. Clin Neurophysiol 2013;124:1928-34
   PubMed Web of Science ®Google Scholar
• Uncini A, Lugaresi A. Fisher syndrome with tetraparesis and antibody to GQ1b: evidence for motor nerve terminal block. Muscle Nerve 1999;22:640-4
   PubMedGoogle Scholar
• Umapathi T, Tan EY, Kokubun N, et al. Non-demyelinating, reversible conduction failure in Fisher syndrome and related disorders. J Neurol Neurosurg Psychiatry 2012;83:941-8
   PubMed Web of Science ®Google Scholar
• Shahrizaila N, Goh KJ, Kokubun N, et al. Sensory nerves are frequently involved in the spectrum of Fisher syndrome. Muscle Nerve 2014;49:558-63
   Google Scholar
• Chan YC, Ahmad A, Paliwal P, Yuki N. Non-demyelinating, reversible conduction failure in a case of pharyngeal–cervical–brachial weakness overlapped by Fisher syndrome. J Neurol Sci 2012;321:103-6
   Google Scholar
• Gürsoy AE, Kolukısa M, Babacan-Yıldız G, et al. Reversible conduction failure in overlap of Miller Fisher syndrome and pharyngeal–cervical–brachial variant of Guillain-Barré syndrome in the spectrum of nodo-paranodopathies. J Clin Neurosci 2014;21:1269-71
   Google Scholar
• Blum S, Csurhes P, Reddel S, et al. Killer immunoglobulin-like receptor and their HLA ligands in Guillain–Barré syndrome. J Neuroimmunol 2014;267:92-6
   Google Scholar
• Hou HQ, Miao J, Feng XD, et al. Changes in lymphocyte subsets in patients with Guillain-Barré syndrome treated with immunoglobulin. BMC Neurol 2014;14:202
   Google Scholar
• Han RK, Cheng YF, Zhou SS, et al. Increased circulating Th17 cell populations and elevated CSF osteopontin and IL-17 concentrations in patients with Guillain-Barré syndrome. J Clin Immunol 2014;34:94-103
   PubMed Web of Science ®Google Scholar
• Li S, Jin T, Zhang HL, et al. Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments. Mediators Inflamm 2014;2014:740947
   PubMed Web of Science ®Google Scholar
• Maddur MS, Rabin M, Hegde P, et al. Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain-Barré syndrome patients. Immuol Res 2014;60:320-9
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Vignali DAA, Rudensky AY, et al. The plasticity and stability of regulatory T cells. Nat Rev Immunol 2013;13:461-7
   PubMed Web of Science ®Google Scholar
• Chiang S, Ubogu EE. The role of chemokines in Guillain-Barré syndrome. Muscle Nerve 2013;48:320-30
   PubMed Web of Science ®Google Scholar
• Yuan F, Yosef N, Reddy CL, et al. CCR2 gene deletion and pharmacologic blockade ameliorate a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome. PLoS One 2014;9:e90463
   PubMed Web of Science ®Google Scholar
• Derksen A, Ritter C, Athar P, et al. Sural sparing pattern discriminates Guillain-Barré syndrome from its mimics. Muscle Nerve 2014;50:780-4
   PubMed Web of Science ®Google Scholar
• Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27(Suppl):S21.24
   Google Scholar
• Van der Meché FG, Van Doorn PA, Meulstee J, Jennekens FG. GBS-consensus group of the Dutch Neuromuscular Research Support Centre. Diagnostic and classification criteria for the Guillain-Barré syndrome. Eur Neurol 2001;45:133-9
   PubMed Web of Science ®Google Scholar
• Sejvar JJ, Kohl KS, Gidudu J, et al. Guillain–Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2011;29:599-612
   PubMed Web of Science ®Google Scholar
• Wakerley BR, Uncini A, Yuki N; for the GBS Classification Group. Guillain-Barré and Miller Fisher syndromes-new diagnostic classification. Nat Rev Neurol 2014;10:537-44
   PubMed Web of Science ®Google Scholar
• van den Berg B, Fokke C, Drenthen J, et al. Paraparetic Guillain-Barré syndrome. Neurology 2014;82:1984-9
   PubMed Web of Science ®Google Scholar
• Mateen FJ, Cornblath DR, Jafari H, et al. Guillain–Barré Syndrome in India: Population-based validation of the Brighton criteria. Vaccine 2011;29:9697-701
   Google Scholar
• Choe YJ, Cho H, Bae GR, Lee JK. Guillain–Barré syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition. Vaccine 2011;29:2066-70
   Google Scholar
• Fokke C, van den Berg B, Drenthen J, et al. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain 2014;137:33-43
   PubMed Web of Science ®Google Scholar
• Wong AHY, Umapathi T, Nishimoto Y, et al. Cytoalbuminologic dissociation in Asian patients with Guillain-Barré and Miller Fisher syndromes. J Peripher Nerv Syst 2015. [ Epub ahead of print]
   Web of Science ®Google Scholar
• Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China: Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605
   PubMed Web of Science ®Google Scholar
• Hadden RDM, Cornblath DR, Hughes RAC, et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Ann Neurol 1998;44:780-8
   PubMed Web of Science ®Google Scholar
• Uncini A, Kuwabara S. Electrodiagnostic criteria for Guillain-Barré syndrome: a critical revision and the need for an update. Clin Neurophysiol 2012;123:1487-95
   PubMed Web of Science ®Google Scholar
• Rajabally YA, Durand M-C, Mitchell J, et al. Electrophysiological diagnosis of Guillain–Barré syndrome subtype: could a single study suffice? J Neurol Neurosurg Psychiatry 2015;86:115-19
   Google Scholar
• Uncini A, Zappasodi F, Notturno F. Electrodiagnosis of GBS subtypes by a single study: not yet the squaring of the circle. J Neurol Neurosurg Psychiatry 2015;86:5-8
   PubMed Web of Science ®Google Scholar
• Shahrizaila N, Goh KJ, Abdullah S, et al. Two sets of nerve conduction studies may suffice in reaching a reliable electrodiagnosis in Guillain–Barré syndrome. Clin Neurophysiol 2013;124:1456-9
   PubMed Web of Science ®Google Scholar
• Gallardo E, Sedano MJ, Orizaola P, et al. Spinal nerve involvement in early Guillain–Barré syndrome: a clinico-electrophysiological, ultrasonographic and pathological study. Clin Neurophysiol 2014. [Epub ahead of print]
   Google Scholar
• Kerasnoudis A, Pitarokoili K, Behrendt V, et al. Correlation of nerve ultrasound, electrophysiological, and clinical findings in post Guillain−Barré syndrome. J Peripher Nerv Syst 2013;18:232-40
   Google Scholar
• Kerasnoudis A, Pitarokoili K, Behrendt V, et al. Increased cerebrospinal fluid protein and motor conduction studies as prognostic markers of outcome and nerve ultrasound changes in Guillain–Barré syndrome. J Neurol Sci 2014;340:37-43
   Google Scholar
• Grimm A, Décard BF, Axer H. Ultrasonography of the peripheral nervous system in the early stage of Guillain-Barré syndrome. J Peripher Nerv Syst 2014;19:234-41
   Google Scholar
• Berciano J, Gallardo E, Sedano MJ, et al. Nerve ultrasonography in early Guillain-Barré syndrome: a need for large prospective studies. J Peripher Nerv Syst 2014;19:344
   Google Scholar
• Ruts L, Drenthen J, Jacobs BC, van Doorn PA. On behalf of the Dutch GBS Study Group. Distinguishing acute-onset CIDP from fluctuating Guillain–Barré Syndrome. Neurology 2010;74:1680-6
   PubMed Web of Science ®Google Scholar
• Kerasnoudis A, Pitarokoili K, Behrendt V, et al. Nerve ultrasound score in distinguishing chronic from acute inflammatory demyelinating polyneuropathy. Clin Neurophysiol 2014;125:635-41
   Google Scholar
• Kerasnoudis A, Pitarokoili K, Behrendt V, et al. Bochum ultrasound score versus clinical and electrophysiological parameters in distinguishing acute-onset chronic from acute inflammatory demyelinating polyneuropathy. Muscle Nerve 2014. [ Epub ahead of print]
   Google Scholar